Lasa Supergenerics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, sales was INR 548.59 million compared to INR 625.4 million a year ago. Revenue was INR 549.46 million compared to INR 625.53 million a year ago. Net loss was INR 49.72 million compared to INR 186.91 million a year ago. Basic loss per share from continuing operations was INR 0.99 compared to INR 4.6 a year ago. Diluted loss per share from continuing operations was INR 0.99 compared to INR 4.6 a year ago.